Foppe Oldenburger

4.0k total citations · 1 hit paper
45 papers, 2.3k citations indexed

About

Foppe Oldenburger is a scholar working on Pediatrics, Perinatology and Child Health, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Foppe Oldenburger has authored 45 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Pediatrics, Perinatology and Child Health, 15 papers in Pulmonary and Respiratory Medicine and 14 papers in Molecular Biology. Recurrent topics in Foppe Oldenburger's work include Childhood Cancer Survivors' Quality of Life (16 papers), Renal and related cancers (11 papers) and Glioma Diagnosis and Treatment (8 papers). Foppe Oldenburger is often cited by papers focused on Childhood Cancer Survivors' Quality of Life (16 papers), Renal and related cancers (11 papers) and Glioma Diagnosis and Treatment (8 papers). Foppe Oldenburger collaborates with scholars based in Netherlands, United Kingdom and Germany. Foppe Oldenburger's co-authors include Flora E. van Leeuwen, Leontien C.M. Kremer, Helena J. H. van der Pal, Caro C.E. Koning, Huib N. Caron, Mathilde C. Cardous-Ubbink, Richard C. Heinen, Piet Bakker, Cor van den Bos and Maud M. Geenen and has published in prestigious journals such as The Lancet, JAMA and Journal of Clinical Oncology.

In The Last Decade

Foppe Oldenburger

44 papers receiving 2.3k citations

Hit Papers

1 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Medical Assessment of Adverse Health Outcomes in Long-term Survivors of Childhood Cancer

2007 597 citations Maud M. Geenen, Mathilde C. Cardous-Ubbink et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Foppe Oldenburger Netherlands	24	1.1k	663	560	495	475	45	2.3k
Rita E. Weathers United States	23	1.2k 1.0×	481 0.7×	883 1.6×	365 0.7×	482 1.0×	40	2.4k
Mike Hawkins United Kingdom	24	920 0.8×	415 0.6×	570 1.0×	246 0.5×	387 0.8×	34	1.8k
Ellen Ruud Norway	31	1.0k 0.9×	324 0.5×	721 1.3×	353 0.7×	437 0.9×	119	2.4k
Pauline Mitby United States	22	1.8k 1.6×	511 0.8×	1.4k 2.4×	335 0.7×	596 1.3×	34	3.3k
Caro C.E. Koning Netherlands	24	923 0.8×	610 0.9×	591 1.1×	187 0.4×	527 1.1×	50	2.2k
Lars Hjorth Sweden	23	870 0.8×	628 0.9×	607 1.1×	216 0.4×	438 0.9×	80	2.2k
Natia Esiashvili United States	27	538 0.5×	965 1.5×	414 0.7×	382 0.8×	534 1.1×	112	2.5k
H Hertz Denmark	28	1.1k 0.9×	356 0.5×	907 1.6×	339 0.7×	456 1.0×	86	2.3k
L. L. Robison United States	18	1.2k 1.1×	402 0.6×	948 1.7×	194 0.4×	447 0.9×	26	2.6k
Karsten Nysom Denmark	25	797 0.7×	240 0.4×	740 1.3×	263 0.5×	425 0.9×	109	2.0k

Countries citing papers authored by Foppe Oldenburger

Since Specialization

Citations

This map shows the geographic impact of Foppe Oldenburger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Foppe Oldenburger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Foppe Oldenburger more than expected).

Fields of papers citing papers by Foppe Oldenburger

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Foppe Oldenburger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Foppe Oldenburger. The network helps show where Foppe Oldenburger may publish in the future.

Co-authorship network of co-authors of Foppe Oldenburger

This figure shows the co-authorship network connecting the top 25 collaborators of Foppe Oldenburger. A scholar is included among the top collaborators of Foppe Oldenburger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Foppe Oldenburger. Foppe Oldenburger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Roelofs, Erik, Inge Compter, Yvonne L.B. Klaver, et al.. (2021). The ROCOCO performance scoring system translates dosimetric differences into clinically relevant endpoints: Comparing IMPT to VMAT in an example pilocytic astrocytoma dataset. Clinical and Translational Radiation Oncology. 28. 32–38. 2 indexed citations

Oldenburger, Eva, Foppe Oldenburger, Annemarie Coolbrandt, et al.. (2020). The use of patient reported outcome measures (PROMs) in palliative radiotherapy: A topical review. Radiotherapy and Oncology. 149. 94–103. 14 indexed citations

Hol, Janna A., Marta López‐Yurda, Harm van Tinteren, et al.. (2019). Prognostic significance of age in 5631 patients with Wilms tumour prospectively registered in International Society of Paediatric Oncology (SIOP) 93-01 and 2001. PLoS ONE. 14(8). e0221373–e0221373. 28 indexed citations

Fajardo, Raquel Dávila, Eva Oldenburger, Christian Rübe, et al.. (2018). Evaluation of boost irradiation in patients with intermediate‐risk stage III Wilms tumour with positive lymph nodes only: Results from the SIOP‐WT‐2001 Registry. Pediatric Blood & Cancer. 65(8). e27085–e27085. 8 indexed citations

Pritchard‐Jones, Kathy, Christophe Bergeron, Beatriz de Camargo, et al.. (2015). Omission of doxorubicin from the treatment of stage II–III, intermediate-risk Wilms' tumour (SIOP WT 2001): an open-label, non-inferiority, randomised controlled trial. The Lancet. 386(9999). 1156–1164. 129 indexed citations

Graf, Norbert, Harm van Tinteren, Christophe Bergeron, et al.. (2012). Characteristics and outcome of stage II and III non-anaplastic Wilms’ tumour treated according to the SIOP trial and study 93-01. European Journal of Cancer. 48(17). 3240–3248. 61 indexed citations

Knijnenburg, Sebastiaan L., Monique Jaspers, Helena J. H. van der Pal, et al.. (2012). Renal Dysfunction and Elevated Blood Pressure in Long-Term Childhood Cancer Survivors. Clinical Journal of the American Society of Nephrology. 7(9). 1416–1427. 61 indexed citations

Zwaan, C. Michel, Bernd Granzen, Lisa Lassay, et al.. (2012). Multimodal treatment, including interferon beta, of nasopharyngeal carcinoma in children and young adults. Cancer. 118(19). 4892–4900. 75 indexed citations

Mulder, Renée L., Leontien C.M. Kremer, Bart G.P. Koot, et al.. (2012). Surveillance of hepatic late adverse effects in a large cohort of long-term survivors of childhood cancer: Prevalence and risk factors. European Journal of Cancer. 49(1). 185–193. 19 indexed citations

10.

Oldenburger, Foppe, et al.. (2011). IS THE RADIOTHERAPY BOOST TO MACROSCOPIC RESIDUAL TUMOR INDICATED?. UCL Discovery (University College London). 1 indexed citations

11.

Pritchard‐Jones, Kathy, Norbert Graf, Christophe Bergeron, et al.. (2011). Doxorubicin can be safely omitted from the treatment of stage II/III, intermediate risk histology wilms tumour: results of the siop wt 2001 randomised trial [Abstract]. ORCA Online Research @Cardiff (Cardiff University). 1 indexed citations

12.

Graf, Norbert, Harm van Tinteren, Kathy Pritchard‐Jones, et al.. (2011). Is the absolute blastema volume after preoperative chemotherapy in nephroblastoma relevant for prognosis? [Abstract]. ORCA Online Research @Cardiff (Cardiff University). 4 indexed citations

13.

Mulder, Renée L., Helena J. H. van der Pal, Paul Bresser, et al.. (2011). Pulmonary function impairment measured by pulmonary function tests in long-term survivors of childhood cancer. Thorax. 66(12). 1065–1071. 50 indexed citations

14.

Dijk, Irma W.E.M. van, Foppe Oldenburger, Mathilde C. Cardous-Ubbink, et al.. (2010). Evaluation of Late Adverse Events in Long-Term Wilms' Tumor Survivors. International Journal of Radiation Oncology*Biology*Physics. 78(2). 370–378. 58 indexed citations

15.

Janssens, Geert O., Corrie Gidding, Erik J. van Lindert, et al.. (2008). The Role of Hypofractionation Radiotherapy for Diffuse Intrinsic Brainstem Glioma in Children: A Pilot Study. International Journal of Radiation Oncology*Biology*Physics. 73(3). 722–726. 42 indexed citations

16.

Sminia, Peter, Foppe Oldenburger, Ben J. Slotman, Christoph Schneider, & Maarten C.C.M. Hulshof. (2002). Re-Irradiation of the Human Spinal Cord. Strahlentherapie und Onkologie. 178(8). 453–456. 28 indexed citations

17.

Michiels, Erna, et al.. (2000). Are clinical parameters valuable prognostic factors in childhood primitive neuroectodermal tumors?. Radiotherapy and Oncology. 54(3). 229–238. 13 indexed citations

18.

Garssen, Bert, et al.. (1998). Fatigue and radiotherapy: (A) experience in patients undergoing treatment. British Journal of Cancer. 78(7). 899–906. 166 indexed citations

19.

Burgers, J. M. V., Foppe Oldenburger, Jan de Kraker, et al.. (1997). Ewing’s sarcoma of the pelvis: changes over 25 years in treatment and results. European Journal of Cancer. 33(14). 2360–2367. 28 indexed citations

20.

Burgers, J. M. V., C. R. Staalman, Jan de Kraker, et al.. (1997). Vertebral abnormalities after treatment for Ewing sarcoma. Medical and Pediatric Oncology. 28(1). 54–58. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact